The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Considering the years of retirement is essential for effective financial planning. Evaluate your needs and prepare for a comfortable future.
21,046 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
The FCC has approved the Nexstar-Tegna deal, creating a national local television powerhouse with 265 stations across...
Rivian and NIO shares fell about 7% amid renewed skepticism about rapid EV growth. Investors are demanding clear prof...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
Walmart stock faces a balanced 2026–2030 path, with growth from e-commerce and membership services battling cost pres...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
Goldman Sachs upgrades Verizon with a higher price target as the carrier commits to a new reporting framework and ong...
Progressive lawmakers unveiled a bill to halt new data centers for two years while federal safeguards for energy, lab...
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
Shield AI just unveiled a landmark Series G round worth $1.5 billion, lifting its valuation to $12.7 billion and sett...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
NVIDIA delivered blockbuster AI-focused results that strengthen a nvidia buy thesis, while Palantir faces valuation h...